Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
about
Neither serotonin nor adenosine-dependent mechanisms preserve ventilatory capacity in ALS ratsTherapeutic potential of intermittent hypoxia: a matter of dose.Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.Nursing role in the multidisciplinary management of motor neurone disease.Acute intermittent hypoxia induced phrenic long-term facilitation despite increased SOD1 expression in a rat model of ALS.Management of respiration in MND/ALS patients: an evidence based review.Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosisPractice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyVentilatory control in ALS.The Impact of High-Frequency Chest Wall Oscillation on Healthcare Use in Patients with Neuromuscular Diseases.Phrenic nerve conduction studies as a biomarker of respiratory insufficiency in amyotrophic lateral sclerosis.Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis.Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis.Safety, tolerability, and efficacy of high-frequency chest wall oscillation in pediatric patients with cerebral palsy and neuromuscular diseases: an exploratory randomized controlled trial.Mechanisms of Enhanced Phrenic Long-Term Facilitation in SOD1G93A Rats.Phrenic long-term facilitation following intrapleural CTB-SAP-induced respiratory motor neuron death.Non-invasive measurement of abnormal ventilatory mechanics in amyotrophic lateral sclerosis.Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis.THEME 4 RESPIRATORY AND NUTRITIONAL MANAGEMENTSafety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosisCombined respiratory training in an individual with C9orf72 amyotrophic lateral sclerosis
P2860
Q33617813-71A7924E-D911-4B98-8840-CD23072CE657Q35043452-E2391095-3D38-4095-A5F1-A1714B25B220Q35809317-C57AB8D2-9B44-44C7-9D82-C17DD1AC829BQ36063178-D8EEB261-7E75-4309-8333-5837F13C49C5Q36278903-3C07950B-2CF1-4888-9CBB-5BB318D8B95BQ36425112-27275C1D-1F34-4994-9A7F-017B1B47DABBQ37070017-374224BC-CDBF-4018-97D5-0514493543CDQ37613342-FF9C73D8-B974-4AC8-8CD7-0E5FF677FD2CQ38108422-89063F4E-D54B-4109-BAAC-2ECD982A83D0Q39901894-3CDF1844-7B27-4FB0-A9B9-DDE01BDDC711Q40262013-0E5C89C2-D26F-4C8B-99A7-66ADE1095891Q40471677-72CF596A-7A04-4FB0-8150-B8446F01DB71Q42285046-BBAC7988-582E-4DA7-96CE-4508D68FE915Q45332845-6690F51D-0FAB-422B-9B4F-55ED3F5A5517Q47134004-26A3942A-5B32-4F4F-B718-047262ABD64BQ47797776-FE4B7049-DF33-43B4-9EEB-2CD4E81E050DQ51549864-CE2C0E5B-EED7-40B5-9920-A1C0BDA63067Q53040216-2D80BC78-54A4-4213-ADA5-C4E76FB6194DQ58153017-5A8D735E-B690-440C-A4FE-589AF41769FEQ58250570-F6DD217D-E2D2-426E-A319-7460230A4E9AQ58726621-477E7395-5653-4EA1-8DA1-3EAD1FF27F92
P2860
Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
@ast
Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
@en
Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
@nl
type
label
Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
@ast
Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
@en
Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
@nl
prefLabel
Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
@ast
Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
@en
Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
@nl
P2093
P1476
Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
@en
P2093
Charles M Wiener
Gregory B Diette
Jeffery Rothstein
Lora Clawson
Noah Lechtzin
P356
10.1080/146608202317576480
P577
2002-03-01T00:00:00Z